Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources

Medical Physics

Volumn 36, Issue 4, 2009, Pages 1452-1458

  Meigooni, Ali S ^a,b   Luerman, Christine M ^b   Sowards, Keith T ^c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Brachytherapy; Dose volume histogram; Prostate implant

Indexed keywords

DOSIMETRY; GRAPHIC METHODS; ONCOLOGY; RADIOTHERAPY;

BRACHYTHERAPY; CLINICAL APPLICATION; DOSE DISTRIBUTIONS; DOSE-VOLUME HISTOGRAMS; DOSIMETRIC PARAMETER; INTERNAL STRUCTURE; PROSTATE IMPLANTS; QUALITATIVE EVALUATIONS;

UROLOGY;

IODINE 125; PALLADIUM 103;

ARTICLE; BRACHYTHERAPY; DOSIMETRY; HISTOGRAM; IMPLANTATION; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION;

AIR; ALGORITHMS; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS;

EID: 63849187813     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3095776     Document Type: Article

References (85)

1. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43.," Med. Phys. 0094-2405 10.1118/1.597458 22, 209-233 (1995).
2. M. Rivard, B. Coursey, L. DeWard, W. Hanson, M. Huq, G. Ibbott, M. Mitch, R. Nath, and J. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 0094-2405 10.1118/1.1646040 31, 633-674 (2004).
3. S. -T. Chiu-Tsao, L. L. Anderson, K. O'Brien, and R. Sanna, " Dose rate determination for I 125 seeds.," Med. Phys. 0094-2405 10.1118/1.596586 17, 815-825 (1990).
4. J. F. Williamson, " Comparison of measured and calculated dose rates in water near I 125 and I 192 r seeds.," Med. Phys. 0094-2405 10.1118/1.596631 18, 776-786 (1991).
5. H. Hedtjarn, G. A. Carlsson, and J. F. Williamson, " Monte Carlo-aided dosimetry of the Symmetra model 125.S06 I 125, interstitial brachytherapy seed.," Med. Phys. 0094-2405 10.1118/1.598990 27, 1076-1085 (2000).
6. R. Nath, A. S. Meigooni, P. Muench, and A. Melillo, " Anisotropy functions for P 103 d, I 125, and I 192 r interstitial brachytherapy sources.," Med. Phys. 0094-2405 10.1118/1.597110 20, 1465-1473 (1993).
7. R. S. Sloboda and G. V. Menon, " Experimental determination of the anisotropy function and anisotropy factor for model 6711 I 125 seeds.," Med. Phys. 0094-2405 10.1118/1.1287285 27, 1789-1799 (2000).
8. E. E. Furhang and L. L. Anderson, " Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43.," Med. Phys. 0094-2405 10.1118/1.598497 26, 153-160 (1999).
9. R. Nath, A. S. Meigooni, and J. A. Meli, " Dosimetry on transverse axes of I 125 and I 192 r interstitial brachytherapy sources.," Med. Phys. 0094-2405 17, 1032-1040 (1990).
10. K. A. Weaver, V. Smith, D. Huang, C. Barnett, M. C. Schell, and C. Ling, " Dose parameters of I 125 and I 192 r seed sources.," Med. Phys. 0094-2405 10.1118/1.596322 16, 636-643 (1989).
11. J. F. Williamson, in Proceedings of 2000 World Congress on Medical Physics and Biomedical Engineering, edited by, G. D. Fullerton, (IEEE Engineering Medicine and Biology Society, Chicago, 2000), Paper No. MO E309-02.
12. Z. Chen and R. Nath, " Dose rate constant and energy spectrum of interstitial brachytherapy sources.," Med. Phys. 0094-2405 10.1118/1.1333748 28, 86-96 (2001).
13. E. Mainegra, R. Capote, and E. Lo'pez, " Radial dose functions for P 103 d, I 125, Y 169 b, and I 192 r brachytherapy sources: An EGS4 Monte Carlo study.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/45/3/309 45, 703-717 (2000).
14. R. Capote, E. Mainegra, and E. Lopez, " Anisotropy functions for low energy interstitial brachytherapy sources: An EGS4 Monte Carlo study.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/46/1/310 46, 135-150 (2001).
15. M. Schell, C. C. Ling, Z. C. Gromadzki, and K. R. Working, " Dose distributions of model 6702 I 125 seeds in water.," Int. J. Radiat. Oncol., Biol., Phys. 13, 795-799 (1987). 0360-3016
16. C. Zheu and F. Inanc, " Integral-transport-based deterministic brachytherapy dose calculations.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/48/1/306 48, 73-93 (2003).
17. S. N. Rustgi, " Photon spectral characteristics of a new double-walled iodine-125 source.," Med. Phys. 0094-2405 10.1118/1.596780 19, 927-931 (1992).
18. R. Nath and A. Mellilo, " Dosimetric characteristics of a double wall I 125 source for interstitial brachytherapy.," Med. Phys. 0094-2405 10.1118/1.597158 20, 1475-1483 (1993).
19. A. S. Meigooni, D. M. Gearheart, and K. Sowards, " Experimental determination of dosimetric characteristics of Best I 125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1289256 27, 2168-2173 (2000).
20. R. Nath and N. Yue, " Dosimetric characterization of an encapsulated interstitial brachytherapy source of I 125 on a tungsten substrate.," Brachytherapy 1538-4721 10.1016/S1538-4721(02)00010-7 1, 102-109 (2002).
21. K. Sowards and A. S. Meigooni, " Monte Carlo evaluation of the dosimetric characteristics of the Best model 2301 I 125 brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(02)00124-0 57, 327-333 (2002).
22. Z. Li, J. J. Fan, and J. R. Palta, " Experimental measurements of dosimetric parameters on the transverse axis of a new I 125 source.," Med. Phys. 0094-2405 10.1118/1.599005 27, 1275-1280 (2000).
23. J. J. DeMarco, R. E. Wallace, and K. Boedeker, " An analysis of MCNP cross-sections and tally methods for low-energy photon emitters.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/8/307 47, 1321-1332 (2002).
24. K. A. Weaver, V. Smith, D. Huang, C. Barnett, M. C. Schell, and C. Ling, " Dose parameters of I 125 and I 192 r seed sources.," Med. Phys. 0094-2405 10.1118/1.596322 16, 636-643 (1989).
25. A. S. Meigooni, S. A. Dini, S. B. Awan, K. Dou, and R. Koona, " A theoretical and experimental determination of dosimetric characteristics for ADVANTAGE P 103 d brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/j.apradiso.2006.03.015 64, 881-887 (2006).
26. J. F. Williamson, " Dosimetric characteristics of the DraxImage model LS-1 I 125 interstitial brachytherapy source design: A Monte Carlo investigation.," Med. Phys. 0094-2405 10.1118/1.1452733 29, 509-521 (2002).
27. D. M. Gearheart, A. Drogin, K. Sowards, A. S. Meigooni, and G. S. Ibbott, " Dosimetric characteristics of a new I 125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1290486 27, 2278-2285 (2000).
28. R. Nath and N. Yue, " Dose distribution along the transverse axis of a new I 125 source for interstitial brachytherapy.," Med. Phys. 0094-2405 10.1118/1.1319520 27, 2536-2540 (2000).
29. G. S. Ibbott and R. Nath, " Dose-rate constant for Imagyn I 125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1359443 28, 705 (2001).
30. G. S. Ibbott, A. S. Meigooni, and D. M. Gearheart, " Monte Carlo determination of dose rate constant.," Med. Phys. 0094-2405 10.1118/1.1489046 29, 1637-1638 (2002).
31. J. I. Monroe and J. F. Williamson, " Monte Carlo-aided dosimetry of the Theragenics TheraSeed model 200 P 103 d interstitial brachytherapy seed.," Med. Phys. 0094-2405 10.1118/1.1460876 29, 609-621 (2002).
32. J. F. Williamson, " Monte Carlo modeling of the transverse-axis dose distribution of the model 200 P 103 d interstitial brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.598924 27, 643-654 (2000).
33. S. -T. Chiu-Tsao and L. L. Anderson, " Thermoluminescent dosimetry for P 103 d seeds (model 200) in solid water phantom.," Med. Phys. 0094-2405 18, 449-452 (1991).
34. R. Nath, N. Yue, K. Shahnazi, and P. J. Bongiorni, " Measurement of dose-rate constant for P 103 d seeds with air-kerma strength calibration based upon a primary national standard.," Med. Phys. 0094-2405 10.1118/1.598925 27, 655-658 (2000).
35. A. S. Meigooni, S. Sabnis, and R. Nath, " Dosimetry of 103Pd brachytherapy sources for permanent implant.," Endocurietherapy/ Hyperthermia Oncology 6, 107-117 (1990). 0094-2405
36. N. Yue and R. Nath, " Experimental determination of the anisotropy function for the model 200 P 103 d light seed' and derivation of the anisotropy constant based upon the linear quadratic model.," Med. Phys. 0094-2405 10.1118/1.1481876 29, 1120-1129 (2002).
37. R. E. Wallace and J. J. Fan, " Dosimetric characterization of a new design P 103 d brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.598765 26, 2465-2470 (1999).
38. G. Luxton, " Comparison of radiation dosimetry in water and solid phantom materials for I 125 and P 103 d brachytherapy sources: EGS4 Monte Carlo study.," Med. Phys. 0094-2405 10.1118/1.597317 21, 631-641 (1999).
39. R. E. Wallace, " On the conversion of dosimetric data among phantom materials for I 125 and 103Pd brachytherapy sources using build-up factor methods with spectral conditions.," Med. Phys. 0094-2405 10.1118/1.598416 25, 2190-2196 (1998).
40. Z. Li, J. R. Palta, and J. J. Fan, " Monte Carlo calculations and experimental measurements of dosimetry parameters of a new P 103 d source.," Med. Phys. 0094-2405 10.1118/1.598975 27, 1108-1112 (2000).
41. M. J. Rivard, " A discretized approach to determining TG-43 brachytherapy dosimetry parameters: Case study using Monte Carlo calculations for the MED3633 P 103 d source.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(01)00144-0 55, 775-782 (2001).
42. G. Luxton and G. Jozsef, " Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV: EGS4 Monte Carlo calculation.," Med. Phys. 0094-2405 10.1118/1.598790 26, 2531-2538 (1999).
43. K. Carlsson and A. Ahnesjö, " The collapsed cone superposition algorithm applied to scatter dose calculations in brachytherapy.," Med. Phys. 0094-2405 10.1118/1.1290485 27, 2320-2332 (2000).
44. M. Rivard, W. Butler, L. DeWard, M. Huq, G. Ibbott, A. Meigooni, C. Melhus, M. Mitch, R. Nath, and J. Williamson, " Supplement to the 2004 update of the AAPM Task Group No. 43 Report.," Med. Phys. 0094-2405 10.1118/1.2736790 34, 2187-2205 (2007).
45. K. T. Sowards and A. S. Meigooni, " A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed model 6733 I 125 brachytherapy source.," Brachytherapy 1538-4721 10.1016/S1538-4721(02)00102-2 1, 227-232 (2002).
46. A. S. Meigooni, S. A. Dini, K. Sowards, J. L. Hayes, and A. Al-Otoom, " Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I 125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1470210 29, 939-942 (2002).
47. J. H. Hubbell and S. M. Seltzer, " Tables of X-ray mass attenuation coefficients 1 keV-20 MeV for elements Z=1-92.," National Inst. of Standards and Technology-Ionizing Radiation Division (NISTIR) Report No. 5632, 1995.
48. J. F. Williamson, " Comparison of measured and calculated dose rates in water near I 125 and I 192 r seeds.," Med. Phys. 0094-2405 10.1118/1.596631 18, 776-785 (1991).
49. R. Nath and N. Yue, " Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 Brachyseed," Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(01)00128-2 55, 813-821 (2001).
50. A. S. Meigooni, J. A. Meli, and R. Nath, " A comparison of solid phantoms with water for dosimetry of I 125 model 6702 brachytherapy sources.," Med. Phys. 0094-2405 10.1118/1.596182 15, 695-701 (1988).
51. G. H. Chan and W. V. Prestwich, " Dosimetric properties of the new I 125 BrachySeed model LS-1 source.," Med. Phys. 0094-2405 10.1118/1.1445411 29, 190-200 (2002).
52. J. F. Williamson, " Dosimetric characteristics of the DRAXIMAGE model LS-1 interstitial brachytherapy source design: A Monte Carlo investigation.," Med. Phys. 0094-2405 10.1118/1.1452733 29, 509-521 (2002).
53. R. Wang and R. S. Sloboda, " Monte Carlo dose parameters of the BrachySeed model LS-1 I 125 brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(02)00051-9 56, 805-813 (2002).
54. G. H. Chan, R. Nath, and J. F. Williamson, " On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.," Med. Phys. 0094-2405 10.1118/1.1690712 31, 1040-1045 (2004).
55. D. M. Duggan and B. L. Johnson, " Dosimetry of the I-Plant model 3500 iodine-125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1357456 28, 661-670 (2001).
56. R. E. Wallace, " Model 3500 I 125 brachytherapy source dosimetric characterization.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969-8043(01) 00254-8 56, 581-587 (2002).
57. M. J. Rivard, " Comprehensive Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the model 3500 I-Plant I 125 brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969- 8043(02)00110-0 57, 381-389 (2002).
58. D. M. Duggan, " Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 I 125 brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/j.apradiso. 2004.05.070 61, 1443-1450 (2004).
59. B. Reniers, S. Vynckier, and P. Scalliet, " Dosimetric study of the new InterSource125 iodine seed.," Med. Phys. 0094-2405 10.1118/1.1415072 28, 2285-2288 (2001).
60. B. Reniers, F. Verhaegen, and S. Vynckier, " The radial dose function of low-energy brachytherapy seeds in different solid phantoms: Comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements.," Phys. Med. Biol. 0031-9155 10.1088/0031-9155/49/8/014 49, 1569-1582 (2004).
61. A. S. Meigooni, M. M. Yoe-Sein, A. Y. Al-Otoom, and K. T. Sowards, " Determination of the dosimetric characteristics of InterSource125 iodine brachytherapy source.," Appl. Radiat. Isot. 0969-8043 10.1016/S0969- 8043(01)00258-5 56, 589-599 (2002).
62. B. Reniers, S. Vynckier, and P. Scalliet, " Dosimetric study of a new palladium seed.," Appl. Radiat. Isot. 57 (6), 805-811 (2002).
63. A. S. Meigooni, J. L. Hayes, H. Zhang, and K. Sowards, " Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE I 125 brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1500395 29, 2152-2158 (2002).
64. A. S. Meigooni, J. L. Hayes, H. Zhang, and K. Sowards, " Erratum: Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE I 125 brachytherapy source [Med. Phys. 29, 2152-2158 (2002)].," Med. Phys. 0094-2405 10.1118/1.1538615 30, 279 (2003).
65. T. D. Solberg, J. J. DeMarco, G. Hugo, and R. E. Wallace, " Dosimetric parameters of three new solid core I-125 brachytherapy sources.," J. Appl. Clin. Med. Phys. 1526-9914 10.1120/1.1464086 3, 119-134 (2002).
66. J. F. Williamson, " Monte Carlo evaluation of kerma at a point for photon transport problems.," Med. Phys. 0094-2405 10.1118/1.596069 14, 567-576 (1987).
67. M. J. Rivard, W. M. Buttler, L. A. DeWerd, M. S. Huq, G. S. Ibbott, A. S. Meigooni, C. S. Melhus, M. G. Mitch, R. Nath, and J. F. Williamson, " Supplement to the 2004 update of the AAPM Task Group No. 43 Report.," Med. Phys. 34 (6), 2187-2205 (2007).
68. R. E. Wallace, " Empirical dose characterization of model I125-SL I 125 brachytherapy source in phantom.," Med. Phys. 0094-2405 10.1118/1.1323980 27, 2796-2802 (2000).
69. Z. Li, " Monte Carlo calculations of dosimetry parameters of the Urocor ProstaSeed I 125 source.," Med. Phys. 0094-2405 10.1118/1.1478559 29, 1029-1034 (2002).
70. A. S. Kirov and J. F. Williamson, " Monte Carlo-aided dosimetry of the Source Tech Medical model STM1251 I 125 interstitial brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1367280 28, 764-772 (2001).
71. A. S. Kirov and J. F. Williamson, " Erratum: Monte Carlo-aided dosimetry of the Source Tech Medical model STM1251 I 125 interstitial brachytherapy source [Med. Phys. 28, 764-772 (2001)].," Med. Phys. 0094-2405 10.1118/1.1446107 29, 262-263 (2002).
72. Z. Li and J. F. Williamson, " Measured transverse-axis dosimetric parameters of the model STM1251 I 125 interstitial source.," J. Appl. Clin. Med. Phys. 1526-9914 10.1120/1.1483235 3, 212-217 (2002).
73. S. -T. Chiu-Tsao, T. L. Duckworth, C. -Y. Hsiung, Z. Li, J. F. Williamson, N. S. Patel, and L. B. Harrison, " Thermoluminescent dosimetry of the SourceTech Medical model STM1251 I 125 seed.," Med. Phys. 0094-2405 10.1118/1.1577251 30, 1732-1735 (2003).
74. N. S. Patel, " Thermoluminescent dosimetry of the Symmetra I 125 model I25. S06 interstitial brachytherapy seed.," Med. Phys. 0094-2405 10.1118/1.1388218 28, 1761-1769 (2001).
75. S. W. Peterson and B. Thomadsen, " Measurements of the dosimetric constants for a new P 103 d brachytherapy source.," Brachytherapy 1538-4721 10.1016/S1538-4721(02)00015-6 1, 110-119 (2002).
76. A. S. Meigooni, Z. Bharucha, M. Yoe-Sein, and K. Sowards, " Dosimetric characteristics of the Best double-wall P 103 d brachytherapy source.," Med. Phys. 0094-2405 10.1118/1.1414007 28, 2568-2575 (2001).
77. 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription.," Med. Phys. 27 (4), 634-642 (2000).
78. A. S. Meigooni, S. B. Awan, N. S. Thompson, and S. A. Dini, " Updated Solid Water to water conversion factors for I 125 and P 103 d brachytherapy sources.," Med. Phys. 0094-2405 10.1118/1.2357018 33, 3988-3992 (2006).
79. S. W. Peterson and B. Thomadsen, " Erratum: Measurements of the dosimetric constants for a new P 103 d brachytherapy source.," Brachytherapy 1538-4721 10.1016/S1538-4721(03)00008-4 1, 233 (2002).
80. B. H. Heintz, R. E. Wallace, and J. M. Hevezi, " Comparison of I 125 sources used for permanent interstitial implants.," Med. Phys. 0094-2405 10.1118/1.1359246 28, 671-682 (2001).
81. D. C. Beyer, F. Puente, K. L. Rogers, and E. M. Gurgoze, " Prostate brachytherapy: Comparison of dose distribution with different I 125 source designs.," Radiology 221, 623-627 (2001). 0033-8419
82. J. Williamson, " Dosimetric characteristics of the DRAXIMAGE model LS-1 I 125 interstitial brachytherapy source design: A Monte Carlo investigation.," Med. Phys. 0094-2405 10.1118/1.1452733 29, 509-521 (2002).
83. R. Nath, N. Yue, and E. Roa, " Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of P 103 d -model Pd-1.," Med. Phys. 0094-2405 10.1118/1.1510452 29, 2433-2434 (2002).
84. K. T. Sowards, " Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE P 103 d brachytherapy source.," J. Appl. Clin. Med. Phys. 8, 18-25 (2007).
85. M. Rivard, W. M. Butler, L. DeWard, M. Huq, G. Ibbott, A. S. Meigooni, C. S. Melhus, M. Mitch, R. Nath, and J. Williamson, " Supplement to the 2004 update of the AAPM Task Group No. 43 Report.," Med. Phys. 0094-2405 10.1118/1.2736790 34, 2187-2205 (2007).